Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |